A shocking report represented to be the largest-known of its type “based on analysis of data from an all-payer insurance claims database” suggests abortion drug related complications are 22 times higher than previously thought. According to the report produced by the Ethics and Public Policy Center, the data suggests one in ten women “experience sepsis, infection, hemorrhaging, or another serious adverse event within 45 days following a mifepristone abortion.”
The report states, “The real-world rate of serious adverse events following mifepristone abortions is at least 22 times as high as the summary figure of “less than 0.5 percent” in clinical trials reported on the drug label.”
Indiana’s most recent abortion complications report from the last three months of 2024 shows that 10 of the 15 reported abortion complications resulted from non-surgical abortions. Six of the reported complications are identified as being from abortions using mifepristone and misoprostol. It must be stressed that the Indiana complication numbers only reflect reported complications.
Click here to send a message to your congressman and both U.S. Senators urging that the FDA should immediately investigate the harm mifepristone causes to women and reconsider its approval altogether.
Recent Comments